Clinical
RSSArticles
-
Pediatric Exposures to Toxic Substances in the Home
A high percentage of calls to poison centers each year are for exposures in children younger than the age of 6 years. Many of these calls are prompted by exposures to substances commonly found in the home and can lead to significant morbidity and mortality even when the result of a small, exploratory exposure. An index of suspicion and a knowledge of toxidromes is critical to make an accurate diagnosis in cases of pediatric toxic exposures. Consultation with a medical toxicologist or poison control center is recommended for all suspected toxic ingestions, both for management recommendations and for reporting purposes.
-
Tackling Obesity with Afterschool Programs
This prospective study following 75 low-income middle school students found that adding nutrition education and physical activity requirements to afterschool programming may enhance gains in some health behaviors and weight management.
-
Just How Good is ‘Good’ Cholesterol?
Investigators challenge high-density lipoprotein levels as the standard for predicting cardiovascular disease risk.
-
Persistent Asthma Patients Show More Plaque Buildup, Inflammation
Pulmonary ailment could speed carotid artery damage, create more inflammatory biomarkers.
-
Global Health Officials Announce Updated Name for Monkeypox
The traditional name will be phased out in favor of “mpox.”
-
2022-2023: A Severe Season for Respiratory Syncytial Virus
The 2022-2023 northern hemisphere respiratory syncytial virus (RSV) season began with fury, crowding hospitals and making many young children extremely ill. Meanwhile, advancing research points to potential means of better preventing RSV infection.
-
Limiting Testing in Febrile Young Infants with Abnormal Urinalyses
According to a 26-site study, febrile infants younger than 2 months of age who have abnormal urinalyses are at very low risk of having meningitis and might not necessarily need to be subjected to lumbar puncture.
-
Spironolactone May Help Treat Chronic Alcoholism
Both animal and human studies suggest spironolactone might be a new agent for helping patients with alcohol use disorder cut their intake.
-
Evidence of Clinical Efficacy of Bebtelovimab in COVID-19
In a retrospective study, bebtelovimab demonstrated efficacy similar to Paxlovid in high-risk outpatients with recent onset of COVID-19 who reported mild to moderate symptoms.
-
Importance of Medication Adherence in Ischemic Heart Disease
The results of a subanalysis of the ISCHEMIA trial indicated about one-quarter of patients in both conservative and invasive strategy groups were nonadherent to recommended medical therapy at baseline. Nonadherence was associated with worse health status in both groups at baseline and after one year.